DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Eli Lilly & Co. (NYSE: LLY)



company name or ticker
Company Photos
(Click to zoom)

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval

Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock?

Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled

Novo Nordisk to Start PIONEER Program on Semaglutide

Benzinga's Top Initiations

Eli Lilly's Diabetes Drug May Halt Heart Disease

Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.

Eli Lilly's Alimta Patent Upheld by U.S. District Court

Health Care Sector Update for 08/26/2015: SRPT, LLY

Exelixis' Cancer Drug Gets Breakthrough Therapy Status

See More Articles...